Ambu A/S (OTCMKTS:AMBBY) Sets New 52-Week Low – Should You Sell?

Ambu A/S (OTCMKTS:AMBBYGet Free Report)’s stock price hit a new 52-week low during trading on Tuesday . The stock traded as low as $13.02 and last traded at $13.02, with a volume of 252 shares trading hands. The stock had previously closed at $14.18.

Ambu A/S Stock Down 8.2 %

The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.47 and a current ratio of 2.49. The stock has a market cap of $3.06 billion and a price-to-earnings ratio of 108.50. The business’s 50 day moving average is $16.63 and its 200 day moving average is $18.65.

Ambu A/S Dividend Announcement

The firm also recently announced a dividend, which was paid on Monday, December 23rd. Shareholders of record on Friday, December 6th were given a dividend of $0.0557 per share. The ex-dividend date of this dividend was Friday, December 6th. Ambu A/S’s payout ratio is 16.67%.

About Ambu A/S

(Get Free Report)

Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.

Featured Stories

Receive News & Ratings for Ambu A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambu A/S and related companies with MarketBeat.com's FREE daily email newsletter.